These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 24879666)

  • 1. Favourable outcome in the treatment of carbapenem-resistant Enterobacteriaceae urinary tract infection with high-dose tigecycline.
    Brust K; Evans A; Plemmons R
    J Antimicrob Chemother; 2014 Oct; 69(10):2875-6. PubMed ID: 24879666
    [No Abstract]   [Full Text] [Related]  

  • 2. Tigecycline in treatment of multidrug-resistant Gram-negative bacillus urinary tract infections: a systematic review.
    Brust K; Evans A; Plemmons R
    J Antimicrob Chemother; 2014 Oct; 69(10):2606-10. PubMed ID: 24879669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tigecycline treatment for urinary tract infections: case report and literature review.
    Drekonja DM; Johnson JR
    J Chemother; 2011 Jun; 23(3):168-70. PubMed ID: 21742587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and microbiological outcomes of serious infections with multidrug-resistant gram-negative organisms treated with tigecycline.
    Anthony KB; Fishman NO; Linkin DR; Gasink LB; Edelstein PH; Lautenbach E
    Clin Infect Dis; 2008 Feb; 46(4):567-70. PubMed ID: 18199038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tigecycline resistance among carbapenem-resistant Klebsiella Pneumoniae: Clinical characteristics and expression levels of efflux pump genes.
    Chiu SK; Chan MC; Huang LY; Lin YT; Lin JC; Lu PL; Siu LK; Chang FY; Yeh KM
    PLoS One; 2017; 12(4):e0175140. PubMed ID: 28388651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tigecycline Therapy for Nosocomial Pneumonia due to Carbapenem-Resistant Gram-Negative Bacteria in Critically Ill Patients Who Received Inappropriate Initial Antibiotic Treatment: A Retrospective Case Study.
    Wu X; Zhu Y; Chen Q; Gong L; Lin J; Lv D; Feng J
    Biomed Res Int; 2016; 2016():8395268. PubMed ID: 28044137
    [No Abstract]   [Full Text] [Related]  

  • 7. Should tigecycline be considered for urinary tract infections? A pharmacokinetic re-evaluation.
    Nix DE; Matthias KR
    J Antimicrob Chemother; 2010 Jun; 65(6):1311-2. PubMed ID: 20378673
    [No Abstract]   [Full Text] [Related]  

  • 8. Once daily high dose tigecycline - pharmacokinetic/pharmacodynamic based dosing for optimal clinical effectiveness: dosing matters, revisited.
    Cunha BA; Baron J; Cunha CB
    Expert Rev Anti Infect Ther; 2017 Mar; 15(3):257-267. PubMed ID: 27917692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergence of tigecycline-resistant Klebsiella pneumoniae after tigecycline therapy for complicated urinary tract infection caused by carbapenem-resistant Escherichia coli.
    Tsai HY; Liao CH; Cheng A; Liu CY; Huang YT; Sheng WH; Hsueh PR
    J Infect; 2012 Dec; 65(6):584-6. PubMed ID: 23000236
    [No Abstract]   [Full Text] [Related]  

  • 10. Klebsiella pneumoniae: development of a mixed population of carbapenem and tigecycline resistance during antimicrobial therapy in a kidney transplant patient.
    Rodríguez-Avial C; Rodríguez-Avial I; Merino P; Picazo JJ
    Clin Microbiol Infect; 2012 Jan; 18(1):61-6. PubMed ID: 21722259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ceftazidime-avibactam or best available therapy in patients with ceftazidime-resistant Enterobacteriaceae and Pseudomonas aeruginosa complicated urinary tract infections or complicated intra-abdominal infections (REPRISE): a randomised, pathogen-directed, phase 3 study.
    Carmeli Y; Armstrong J; Laud PJ; Newell P; Stone G; Wardman A; Gasink LB
    Lancet Infect Dis; 2016 Jun; 16(6):661-673. PubMed ID: 27107460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of minocycline against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae clinical isolates, with comparison to doxycycline and tigecycline.
    Chen A; Smith KP; Whitfield BA; Zucchi PC; Lasco TM; Bias TE; Kirby JE; Hirsch EB
    Diagn Microbiol Infect Dis; 2017 Aug; 88(4):365-367. PubMed ID: 28535946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting Antibiotic Resistance in Urinary Tract Infection Patients with Prior Urine Cultures.
    Dickstein Y; Geffen Y; Andreassen S; Leibovici L; Paul M
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4717-21. PubMed ID: 27216064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated to prevalence and treatment of carbapenem-resistant Enterobacteriaceae infections: a seven years retrospective study in three tertiary care hospitals.
    Pang F; Jia XQ; Zhao QG; Zhang Y
    Ann Clin Microbiol Antimicrob; 2018 Mar; 17(1):13. PubMed ID: 29571291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit.
    Sader HS; Jones RN; Dowzicky MJ; Fritsche TR
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):203-8. PubMed ID: 16105565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-drug-resistant Gram-negative bacteria causing urinary tract infections: a review.
    Mazzariol A; Bazaj A; Cornaglia G
    J Chemother; 2017 Dec; 29(sup1):2-9. PubMed ID: 29271736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tigecycline resistance in Australian antibiotic-resistant Gram-negative bacteria.
    Iredell J; Thomas L; Power D; Mendes E
    J Antimicrob Chemother; 2007 Apr; 59(4):816-8. PubMed ID: 17353224
    [No Abstract]   [Full Text] [Related]  

  • 18. An update on the management of urinary tract infections in the era of antimicrobial resistance.
    Bader MS; Loeb M; Brooks AA
    Postgrad Med; 2017 Mar; 129(2):242-258. PubMed ID: 27712137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cefiderocol for Infections Caused by Multidrug-Resistant Gram-Negative Bacteria.
    Weaver K; Stallworth K; Blakely KK
    Nurs Womens Health; 2020 Oct; 24(5):377-382. PubMed ID: 32890463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single daily high-dose tigecycline therapy of a multidrug-resistant (MDR) Klebsiella pneumoniae and Enterobacter aerogenes nosocomial urinary tract infection.
    Cunha BA; McDermott B; Nausheen S
    J Chemother; 2007 Dec; 19(6):753-4. PubMed ID: 18230562
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.